Curriculum Vitae

Current position

2021-current:
Post-doctoral Research Fellow, Division of Endocrinology, Boston Children's Hospital (BCH), Boston, MA, US & Harvard University, Cambridge, MA, US.
Broad Institute of MIT and Harvard University.

Clinical experience

2017-2019
Fellowship in Diabetes Centre, Tzaneio General Hospital of Piraeus, Greece.

2012-2017
Trainee in Internal Medicine/Residency, Department of Internal Medicine Tzaneio, General Hospital of Piraeus, Greece.

2012
Rural doctor."Agios Dionysios" General Hospital of Zakynthos island, Greece.

Research experience

2019-2021
Post-doctoral Research Fellow, Division of Endocrinology, Dept. of Medicine, BIDMC, Harvard Medical School – as part of my Fellowship funded by the Hellenic Endocrine Society (Scholarship in Diabetes).

2017-2018
Co-Investigator in genetic diagnosis of atypical non-autoimmune diabetes in the Mediterranean area. Mediterranean Group for the Study of Diabetes (MGSD). 

2016-2017
Co-Investigator in Randomised Clinical Trial in Type 2 Diabetes (SUSTAIN-7, NCT02648204).

2014-2017
Co-Investigator in Randomised Clinical Trial in Dyslipidemia (FOURIER, NCT01764633). 

2014-2017
Co-Investigator in Randomised Clinical Trial in Dyslipidemia and Cognitive Function (EBBINGHAUS, NCT02207634). 

2015-2019
Research Fellow in Diabetes Center, Tzaneio, General Hospital, Greece.

Data Science Training

2019-present
Data Science Specialization, Johns Hopkins University (online courses) with Certificates in R Programming, Exploratory Data Analysis, Getting and Cleaning Data, and The Data Scientist’s Toolbox. 

2015
Annual Seminar on Introduction to Research Methodology - Statistical Package SPSS, Scientific Council, Tzaneio, General Hospital of Piraeus.

Harvard University; Harvard Catalyst & Harvard T.H. Chan School of Public Health

Completed courses on:

Comparative Effectiveness Research (Data Sources, Cohort, Case-Control & Self-Controlled studies).

Fundamentals of Clinical and Translational Research (FaCToR).

Introduction to Mixed Methods Research.

Introduction to "Omics" Research.

HPM 548: Responsible Conduct of Research.

Funding Your Research: Foundations & Philanthropy.

Project Management Strategies for The Researcher:  Scheduling for Projects, Defining the Work, Creating & Finalizing the Plan.

Training in Clinical Trials 

2021
CITI Program (online courses) Certificates on: Biomedical Research, Conflicts of Interest, HIPAA and Health Information Security.

2019
CITI Program (online courses) Certificates on: Basic Human Subjects Protection Required Training, CITI Good Clinical Practice Course, and IRB Committee Member Training.

2013
Courses on Clinical Trials, Biostatistics and Preventive Medicine.

Cambridge University Hospitals, NHS & Department of Hygiene, Epidemiology & Medical Statistics, Athens University Medical School, Scientific Society of Epidemiology.

2013
Certificate of completion Good Clinical Practice and Regulatory Requirements for Clinical Trials

Cambridge University Hospitals, NHS Foundation Trust.

Honors, Awards, Distinctions

(Selectively) 

2023

Junior Investigator Award
Metabolism – Clinical & Experimental Journal
Highest score by the Associate Editors.
21st World Congress on Insulin Resistance Diabetes & Cardiovascular Disease. Los Angeles, CA, US

Outstanding Reviewer
Annals of Internal Medicine
Recognition Award for the contributions as a a reviewer.

2022

Award in Panhellenic Congress of Obesity.

2021
Recognition Award in design and application of open and reproducible research solutions.

Surrey Open Research and Transparency Showcase, Surrey Reproducibility Society (SRS) and the Surrey Open Research Working Group (ORWG), University of Surrey, UK.

2019, 2020, 2021, & 2022
Reviewer of the Year for the Journal of Diabetes.

2019, 2018 & 2012
Official delegate of Hellenic Diabetes Association in EASD meetings.

2018, 2017, 2013 & 2011
Annual awards in Panhellenic Diabetes Congresses.

2018
Award in Panhellenic Congress in Metabolic Diseases.

2017 & 2016
Annual awards in Panhellenic Congress on Continuing Education in Internal Medicine with International Participation.

2014 (2 awards in Clinical & Basic Science) & 2012
Annual awards in Annual Panhellenic Medical Congress.

2012
Award in Panhellenic Congress of Internal Medicine.

Scholarships & Fellowships

2019-2020
Fellowship in Diabetes for Research in the US, Hellenic Endocrine Society - Panhellenic Association of Endocrinologists, Greece (Postdoctoral Fellowship).

2015
Distinction & Scholarship for Research Protocol, Hellenic Society of Lipidology, Atherosclerosis and Vascular Disease, Greece..

2011-2012
Tsakiroglou Foundation, Greece (Ph.D. scholarship).

2011
Hygeia, Foundation Scholarship, Greece (Clinical Fellowship).

2009
Hellenic National Center for Research, Prevention and Treatment of Diabetes Mellitus and its Complications (H.N.D.C.), Greece (part of Ph.D. scholarship).

2001-2007
Papadakis Scholarship, Athens Medical School, National and Kapodistrian University of Athens, Greece (Undergraduate scholarship).

Editorial Activities:

Reviewer

Editor Board Member

Annals of Internal Medicine; Metabolism; Cardiovascular Diabetology; The Journal of Clinical Endocrinology & Metabolism; Journal of Diabetes; BMC Family Practice; BMC Primary Care; Journal of International Medical Research; Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy; Metabolites; International Journal of Molecular Sciences; Nutrients; Journal of Lipids; Archives of Medical Science-Atherosclerotic Diseases; Journal of Inflammation Research; Reviews in Cardiovascular Medicine; Clinical Interventions in Aging; Biomolecules; Pharmaceutical Biology; Open Access Journal of Clinical Trials; Children; Diagnostics; Life; Cells; Nutrition and Cancer; Archives of Medical Science - Atherosclerotic Diseases; Molecular Biology Reports; Vascular Health and Risk Management; Biomedicines; Patient Preference and Adherence; Healthcare; Journal of Personalized Medicine; Journal of Clinical Medicine; European Journal of Clinical Microbiology & Infectious Diseases;Journal of Human Nutrition and Dietetics; International Journal of Environmental Research and Public Health; International Journal of General Medicine; Journal of Diabetes Research; Hormone and Metabolic Research; International Journal of Endocrinology; etc.

(>500 verified peer reviews available on Web of Science)

Journal of Clinical Endocrinology & Metabolism (JCEM)

Metabolism (Metabolism Clinical and Experimental)

Publications

Books

2023
Angelidi AM, Tsoukas MA, Mantzoros CS. Chapter: Lipodystrophy Syndromes. In: DeGroot's Endocrinology Basic Science and Clinical Practice (8th edition), Elsevier (ISBN: 9780323694124)

2019
Melidonis A, Angelidi A. Stroke in Diabetes. In: Current Diabetologia, 1st edition, Hellenic Diabetes Association (Ed), Selida, 2019;51:733-752.

2019
Co-Editor in the Conference Book: Topics in Metabolism.

International peer-reviewed journals 

(Indicatively:)

Early metabolomic, lipid and lipoprotein changes in response to medical and surgical therapeutic approaches to obesity.
Angelidi AM, Kokkinos A, Sanoudou D, Connelly MA, Alexandrou A, Mingrone G, Mantzoros CS. Metabolism. 2023;138:155346.

Circulating levels of five proglucagon-derived peptides in response to intravenous or oral glucose or lipids and to a mixed-meal in subjects with normal weight, overweight, and obesity.
Perakakis N, Kokkinos A, Angelidi AM, Tsilingiris D, Gavrieli A, Yannakoulia M, Tentolouris N, Mantzoros CS.
Clin Nutr. 2022;41(9):1969-1976.

PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses.
Bouzoni E, Perakakis N, Connelly MA, Angelidi AM, Pilitsi E, Farr O, Stefanakis K, Mantzoros CS.
Metabolism. 2022;134:155265.

Novel Noninvasive Approaches to the Treatment of Obesity: From Pharmacotherapy to Gene Therapy.
Angelidi AM*, Belanger MJ*, Kokkinos A*, Koliaki CC*, Mantzoros CS. (*Co-fisrt authorship)
Endocr Rev. 2022;43(3):507-557.

The effect of dietary patterns on non-alcoholic fatty liver disease diagnosed by biopsy or magnetic resonance in adults: a systematic review of randomised controlled trials.
Angelidi AM*, Papadaki A*, Nolen-Doerr E, Boutari C, Mantzoros CS. (*Co-fisrt authorship)
Metabolism. 2022;129:155136.

Neurohormonal Changes in the Gut-Brain Axis and Underlying Neuroendocrine Mechanisms following Bariatric Surgery.
Martinou E, Stefanova I, Iosif E, Angelidi AM.
Int J Mol Sci. 2022;23(6):3339.

Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches.
Martinou E, Pericleous M, Stefanova I, Kaur V, Angelidi AM.
Diagnostics (Basel). 2022;12(2):407.

A Systematic Review on HOX Genes as Potential Biomarkers in Colorectal Cancer: An Emerging Role of HOXB9.
Martinou E, Falgari G, Bagwan I, Angelidi AM.
Int J Mol Sci.2021;22(24):13429.

Deep transfer learning and data augmentation improve glucose levels prediction in type 2 diabetes patients.
Deng Y, Lu L, Aponte L, Angelidi AM, Novak V, Karniadakis GE, Mantzoros CS.
NPJ Digit Med. 2021;4(1):109.

Severe insulin resistance syndromes.
Angelidi AM, Filippaios A, Mantzoros CS.
J Clin Invest. 2021;131:e142245.

Vitamin D status is associated with in-hospital mortality and mechanical ventilation: a cohort of COVID-19 hospitalized patients.
Angelidi AM*, Belanger MJ*, Lorinsky MK, Karamanis D, Chamorro-Pareja N, Ognibene J, Palaiodimos L, Mantzoros CS. (*Co-fisrt authorship).
Mayo Clin Proc. 2021;96(4):875-886.

Mediterranean diet as a nutritional approach for COVID-19.
Angelidi AM, Kokkinos A, Katechaki E, Ros E, Mantzoros CS.
Metabolism. 2021;114:154407.

Covid-19 and Disparities in Nutrition and Obesity.
Belanger MJ, Hill MA, Angelidi AM, Dalamaga M, Sowers JR, Mantzoros CS.
N Engl J Med. 2020;383(11):e69.

COVID-19 and diabetes mellitus: What we know, how our patients should be treated now, and what should happen next.
Angelidi AM*, Belanger MJ*, Mantzoros CS. (*Co-fisrt authorship)
Metabolism. 2020;107:154245.

Is atorvastatin associated with new onset diabetes or deterioration of glycemic control? Systematic review using data from 1.9million patients.
Angelidi AM, Stambolliu E, Adamopoulou KI, Kousoulis AA.
Int J Endocrinol. 2018; 2018:8380192. 

Evaluation of Different Scores to Predict Non-alcoholic Fatty Liver Disease in patients with type 2 diabetes.
Angelidi AM, Papazafiropoulou AK, Tzouganatou E, Anagnostopoulou K, Velissaris V, Markakis E, Vagena E, Melidonis Α.
Hell J Atheroscler 2017;8:103-112. 

Association of matrix γ-carboxyglutamic acid protein levels with insulin resistance and lp(a) in diabetes: a cross-sectional study.
Antonopoulos S*, Mylonopoulou M*, Angelidi A*, Kousoulis A, Tentolouris N. (*Co-fisrt authorship)
Diabetes Res Clin Pract. 2017; 130:252-257

Predictors of left ventricular diastolic dysfunction in type 2 diabetes patients: a 4-year prospective study.
Fousteris E, Papazafiropoulou A, Tountas C, Angelidi A, Matsagos S, Theodosis-Georgilas A, Chantanis S, Fousas S, Melidonis A.
Hellenic J Cardiol. 2016;57(6):457-458.

A palpable painless axillary mass as the clinical manifestation of Castleman’s disease in a patient with hepatitis C disease.
Papazafiropoulou A*, Angelidi A*, Kousoulis A, Christofilidis G, Sagia C, Kaftanidou L, Manoludaki K, Tsavari A, Kranidiotis G, Kamaratos A, Melidonis A. (*Co-fisrt authorship)
Case Rep Med. 2016; 2016:1970276.

The Impact of Continuous Subcutaneous Insulin Infusion Therapy on Efficacy and Safety in a Cohort of Type 1 Diabetes Patients: A 3-Year Prospective Study.
Melidonis A, Kamaratos A, Angelidi A, Thomakos P, Vrakas S, Bakalis J, Fousteris E, Iraklianou S.
Diabetes Technol Ther. 2016;18(3):159-63.

Endothelial progenitor cell as a cardiometabolic risk factor marker in prediabetes. Angelidi A, Melidonis A, Protopsaltis I, Sergentanis T, Gritzapis A, Kornezos I, Economopoulos T, Dimitriadis G, Boutati E, Raptis S.
Hormones (Athens) 2014;13(2):244-251.

Acute steatohepatitis, due to extreme metabolic dysregulation, as the first presentation of non-alcoholic fatty liver disease.
Kranidiotis G, Angelidi A, Sevdalis E, Telios TN, Gougoutsi A, Melidonis A.
Clin Pract. 2013;3(2):e17.

Impact of ADMA, endothelial progenitor cells and traditional cardiovascular risk factors on pulse wave velocity among prediabetic individuals.
Protopsaltis I, Foussas S, Angelidi A, Gritzapis A, Sergentanis TΝ, Matsagos S, Tzirogiannis K, Panoutsopoulos GI, Dimitriadis G, Raptis S, Melidonis A.
Cardiovasc Diabetol. 2012; 11:141.

More than skip deep.
Protopsaltis I, Angelidi A, Milionis HJ, Katsantonis I, Gavra P, Zizi-Sempertzoglou A, Perimeni D, Paschalidis.
N. Am J Med 2009;122(9):830-2.  

Other Publications:

Peer-reviewed publications in Diabetes-Metabolism (national journals): 12

Invited Author in National Conference Books in Diabetes-Metabolism: 9

Abstracts in Diabetes-Metabolism (national journals): 9

Conferences

(Selectively)

55th European Association for the Study of Diabetes (EASD) Annual Meeting 2019, Barcelona, Spain.

Association of anthropometric, socioeconomic, glycaemic and cardiometabolic parameters with the presence and severity of depressive symptoms in type 2 diabetes. Angelidi A, Vrakas S, Papazafiropoulou Α, Verras C, Ganotopoulou A, Melidonis Α. Diabetologia 2019;62(Suppl 1):1.    

54th EASD Annual Meeting 2018, Berlin, Germany.

The predictive role of Endothelial Progenitor Cells and Asymmetric Dimethylarginine in the onset of Type 2 Diabetes Mellitus: A 10-year prospective study.
Angelidi A, Papazafiropoulou Α, Gritzapis Α, Sergentanis Τ, Tzouganatou ΕΜ, Papantoniou S, Efstratiadi E, Matsagos S, Spyropoulou P, Protopsaltis J, Boutati E, Dimitriadis G, Melidonis Α. 
Diabetologia 2018;61:S143-4.

24th European Congress on Obesity 2017, Porto, Portugal.

Evaluation of different scores to predict nonalcoholic fatty liver disease in overweight or obese patients with type 2 diabetes.
Angelidi A, Angelidi M, Papazafiropoulou A, Anagnostopoulou K, Vagena E, Velissaris V, Markakis V, Kamaratos A, Melidonis A.
Obes Facts 2017;10(suppl 1):178.

53rd EASD Annual Meeting 2017, Lisbon, Portugal.

Evaluation of different neurological scores and scales to predict fatal stroke in hospitalised stroke patients with type 2 diabetes.
Angelidi A, Papazafiropoulou A, Tzouganatou EM, Eustratiadi E, Lampropoulos P, Georgopoulos I, Kranidiotis G, Melidonis A.
Diabetologia 60, S517-S517.

Association and predictability of different non-invasive scores with nonalcoholic fatty liver disease diagnosis in patients with type 2 diabetes.
Papazafiropoulou A, Angelidi A, Anagnostopoulou K, Vagena E, Velissaris V,Markakis E,Petropoulou K,Kokolaki A,Bampali V,MelidonisA.
Diabetologia 60, S573-S573.

52nd EASD Annual Meeting 2016, Munich, Germany.

The prognostic role of high sensitivity CRP and triglycerides on the new onset of left ventricular diastolic dysfunction in type 2 diabetes patients: a 4-year prospective study.
Fousteris E, Angelidi A, Papazafiropoulou A, Theodosis-Georgilas A, Verras C, Tountas C, Matsagos S, Kamaratos A, Foussas S, Melidonis A.
Diabetologia 2016;59(Suppl 1):S542.

76th Scientific Sessions, New Orleans, LA, US.

Association of Endothelial Progenitor Cells with Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Prediabetes.
Angelidi A, Papazafiropoulou A, Protopsaltis J, Sergentanis T, Gritzapis A, Matsagos S, Spiropoulou P, Boutati E, Melidonis A.
Diabetes 2016; 65(Suppls 1): A549.

51st EASD Annual Meeting 2016, Stockholm, Sweden.

Association of anxiety, stress and depression with demographic, anthopometric, socioeconomic, glycaemic and cardiometabolic risk factors in patients with type 2 diabetes.
Sereti A, Angelidi A, Verras C, Vrakas S, Papazafiropoulou A, Foutris A, Charpidis K, Liosi V, Gkizlis V, Melidonis A.
Diabetologia 2015;58:S412-3.

Continuous subcutaneous insulin infusion in patients with type 1 diabetes: results of a prospective study with three years of follow up.
Kamaratos A, Angelidi A, Vrakas S, Fousteris E, Verras C, Bakalis I, Sagia C, Efstratiadi E, Bilis A, Iraklianou S, Melidonis A.
Diabetologia 2015;58:S442.

Heart Failure Congress of the European Society of Cardiology, 2014, Athens, Greece.

Association and predictability of the novel ASCVD risk score in the establishment of heart failure in patients with type 2 diabetes: data from a 10-year prospective study.
Angelidi A, Englezopoulos K, Vrakas S, Fousteris E, Destounis A, Sagia C, Mousiama T, Melidonis A, Foussas S.
Eur J Heart Fail 2014;16 (suppl. 2):345.

50th EASD Annual Meeting 2014, Vienna, Austria.

Association of endothelial progenitor cells with asymmetric dimethylarginine and cardiometabolic risk factors in prediabetes.
Angelidi A, Protopsaltis J, Sergentanis T, Gritzapis A, Matsagos S, Misitzi A,Boutati E,Dimitriadis G, Economopoulos T,Raptis S,MelidonisA.
Diabetologia 2014;57:S525-S526.

47th EASD Annual Meeting 2014, Lisbon, Portugal.

Determinants of circulating endothelial progenitor cell number in prediabetic subjects.
Angelidi A, Protopsaltis J, Gritzapis A, Kornezos I, SergentanisT., Tzirogiannis K, Boutati E, Dimitriadis G, Melidonis A, Raptis S.
Diabetologia 2011;54:(Suppl1) S493–S494.

Conferences:

Chairwoman: 3

Invited Speaker: 42

Oral Presentations (national): 53

Poster Presentations (national): 49